Literature DB >> 33064937

An Exonuclease V-qPCR Assay to Analyze the State of the Human Papillomavirus 16 Genome in Cell Lines and Tissues.

Julia E Myers1,2,3, Katarzyna Zwolinska1,2, Martin J Sapp1,2,3, Rona S Scott1,2,3.   

Abstract

Integration of the human papillomavirus (HPV) genome into host cell chromosomes has been observed in a majority of HPV-positive cervical cancers and a subset of oral HPV-associated cancers. HPV integration also occurs in long-term cell culture. Screening for HPV integration can be labor intensive and yield results that are difficult to interpret. Here we describe an assay based on exonuclease V (ExoV/RecBCD) and quantitative polymerase chain reaction (qPCR) to determine if samples from cell lines and tissues contain episomal or integrated HPV. This assay can be applied to screen other small DNA viruses with episomal/linear genome configurations in their viral lifecycle and has the potential to be used in clinical settings to define viral genomic conformations associated with disease.
© 2020 Wiley Periodicals LLC. Basic Protocol: Exonuclease V genomic DNA digestion and qPCR for detection of HPV16 genome configuration in cells Support Protocol: Exonuclease V analysis of HPV16 genome configuration in tissues Alternate Protocol: Determining HPV integration type or integrity of HPV episome. © 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  RecBCD; episomal; exonuclease V; human papillomavirus (HPV); integrated

Mesh:

Substances:

Year:  2020        PMID: 33064937      PMCID: PMC9508936          DOI: 10.1002/cpmc.119

Source DB:  PubMed          Journal:  Curr Protoc Microbiol        ISSN: 1934-8525


  23 in total

1.  Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells.

Authors:  F Luft; R Klaes; M Nees; M Dürst; V Heilmann; P Melsheimer; M von Knebel Doeberitz
Journal:  Int J Cancer       Date:  2001-04-01       Impact factor: 7.396

2.  Characterization of HPV and host genome interactions in primary head and neck cancers.

Authors:  Michael Parfenov; Chandra Sekhar Pedamallu; Nils Gehlenborg; Samuel S Freeman; Ludmila Danilova; Christopher A Bristow; Semin Lee; Angela G Hadjipanayis; Elena V Ivanova; Matthew D Wilkerson; Alexei Protopopov; Lixing Yang; Sahil Seth; Xingzhi Song; Jiabin Tang; Xiaojia Ren; Jianhua Zhang; Angeliki Pantazi; Netty Santoso; Andrew W Xu; Harshad Mahadeshwar; David A Wheeler; Robert I Haddad; Joonil Jung; Akinyemi I Ojesina; Natalia Issaeva; Wendell G Yarbrough; D Neil Hayes; Jennifer R Grandis; Adel K El-Naggar; Matthew Meyerson; Peter J Park; Lynda Chin; J G Seidman; Peter S Hammerman; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

3.  Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.

Authors:  Mark R Pett; M Trent Herdman; Roger D Palmer; Giles S H Yeo; Mahmud K Shivji; Margaret A Stanley; Nicholas Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

4.  Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines.

Authors:  J Chad Brenner; Martin P Graham; Bhavna Kumar; Lindsay M Saunders; Robbi Kupfer; Robert H Lyons; Carol R Bradford; Thomas E Carey
Journal:  Head Neck       Date:  2010-04       Impact factor: 3.147

5.  Genomic architecture and inheritance of human ribosomal RNA gene clusters.

Authors:  Dawn M Stults; Michael W Killen; Heather H Pierce; Andrew J Pierce
Journal:  Genome Res       Date:  2007-11-19       Impact factor: 9.043

Review 6.  Human papillomavirus and cervical cancer.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

Review 7.  The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.

Authors:  Zhen Gooi; Jason Y K Chan; Carole Fakhry
Journal:  Laryngoscope       Date:  2016-02-04       Impact factor: 3.325

Review 8.  The low-risk papillomaviruses.

Authors:  Nagayasu Egawa; John Doorbar
Journal:  Virus Res       Date:  2016-12-28       Impact factor: 3.303

9.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.

Authors:  Keiko Akagi; Jingfeng Li; Tatevik R Broutian; Hesed Padilla-Nash; Weihong Xiao; Bo Jiang; James W Rocco; Theodoros N Teknos; Bhavna Kumar; Danny Wangsa; Dandan He; Thomas Ried; David E Symer; Maura L Gillison
Journal:  Genome Res       Date:  2013-11-07       Impact factor: 9.043

10.  A simple method for sequencing the whole human mitochondrial genome directly from samples and its application to genetic testing.

Authors:  Yue Yao; Motoi Nishimura; Kei Murayama; Naomi Kuranobu; Satomi Tojo; Minako Beppu; Takayuki Ishige; Sakae Itoga; Sachio Tsuchida; Masato Mori; Masaki Takayanagi; Masataka Yokoyama; Kazuyuki Yamagata; Yoshihito Kishita; Yasushi Okazaki; Fumio Nomura; Kazuyuki Matsushita; Tomoaki Tanaka
Journal:  Sci Rep       Date:  2019-11-22       Impact factor: 4.379

View more
  3 in total

1.  A Critical Role for p53 during the HPV16 Life Cycle.

Authors:  Christian T Fontan; Claire D James; Apurva T Prabhakar; Molly L Bristol; Raymonde Otoa; Xu Wang; Elmira Karimi; Pavithra Rajagopalan; Devraj Basu; Iain M Morgan
Journal:  Microbiol Spectr       Date:  2022-05-24

2.  CK2 Phosphorylation of Human Papillomavirus 16 E2 on Serine 23 Promotes Interaction with TopBP1 and Is Critical for E2 Interaction with Mitotic Chromatin and the Viral Life Cycle.

Authors:  Apurva T Prabhakar; Claire D James; Dipon Das; Raymonde Otoa; Matthew Day; John Burgner; Christian T Fontan; Xu Wang; Sarah H Glass; Andreas Wieland; Mary M Donaldson; Molly L Bristol; Renfeng Li; Anthony W Oliver; Laurence H Pearl; Brian O Smith; Iain M Morgan
Journal:  mBio       Date:  2021-09-21       Impact factor: 7.867

3.  Whole Genome Assembly of Human Papillomavirus by Nanopore Long-Read Sequencing.

Authors:  Shuaibing Yang; Qianqian Zhao; Lihua Tang; Zejia Chen; Zhaoting Wu; Kaixin Li; Ruoru Lin; Yang Chen; Danlin Ou; Li Zhou; Jianzhen Xu; Qingsong Qin
Journal:  Front Genet       Date:  2022-01-04       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.